Table 3.
MacDonald Hull and Norris grading for individual lesions among patients of different groups before and after treatment
| MacDonald Hull and Norris grading | Group A N` = 40 |
Group B N` = 62 |
Group C N` = 45 |
Group D N` = 38 |
Total N` = 185 |
p1a | p2a | p3a | p4a | p5a | p6a | p7c |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | ||||||||||||
| G0 | 18 (45%) | 39(62.9%) | 30(66.6%) | 17(44.7%) | 104(56.2%) | |||||||
| G1 | 12 (30%) | 15(24.2) | 7(15.6%) | 9(23.7%) | 43(23.3%) | |||||||
| G2 | 10 (25%) | 7(11.3%) | 7(15.6%) | 8(21.1%) | 32(17.3%) | |||||||
| G3 | 0 (0%) | 1 (1.6%) | 1(2.2%) | 4(10.5%) | 6(3.2%) | |||||||
| G4 | 0 (0%) | 0(0%) | 0(0%) | 0(0%) | 0(0%) | |||||||
|
Mean SD |
0.8 0.82 |
0.52 0.76 |
0.53 0.84 |
0.97 1.05 |
0.67 0.87 |
0.09 | 0.1 | 0.1 | 0.3 | 0.2 | 0.1 | 0.09 |
| After treatment | ||||||||||||
| G0 | 2 (5%) | 5 (8.1%) | 1(2.2%) | 2(5.3%) | 11(5.9%) | |||||||
| G1 | 5(12.5%) | 4 (6.4%) | 4(8.9%) | 4(10.5%) | 15(8.1%) | |||||||
| G2 | 2(5%) | 5 (8.1%) | 6(13.3%) | 4(10.5%) | 14(7.6%) | |||||||
| G3 | 10(25%) | 9 (14.5%) | 9(20%) | 3(7.9%) | 32(17.3%) | |||||||
| G4 | 21(52.5%) | 39(62.9%) | 25(55.6%) | 25(65.8%) | 113(61.1%) | |||||||
|
Mean SD |
3.0.08 1.24 |
3.18 1.3 |
3.18 1.11 |
3.16 1.29 |
3.16 1.23 |
0.4 | 0.7 | 0.4 | 0.5 | 0.8 | 0.6 | 0.7 |
| p value ∞ | 0.00001* b | 0.00001* b | 0.00001* b | 0.00001* b | 0.00001* b | |||||||
N` = number of lesions in each group. Mann–Whitney testa, Wilcoxon test b; Kruskal–Wallis testc, p value ∞ (baseline & post-treatment MacDonald Hull and Norris grade), p1(A,B), p2(A,C), p3(A,D), p4(B,C), p5(B,D), p6(C,D), p7(A,B,C,D)
*Statistical significance